ACN-1052

N/A

Report date: 2025/01/26 15:32:41
NME

Base Information

Drug NameACN-1052
Drug Alias Nameadenosine A3 antagonists (Acorn)ACN-1052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcorn Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcorn Biomedical Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A